Eltrombopag olamine

Product NDC
70069-837
11-digit product format
700690837
Labeler code
70069
Product ID
70069-837_ec6939e2-4f64-4edd-848c-83e73ffac433
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Eltrombopag olamine
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Somerset Therapeutics, LLC
Application
ANDA219638
Marketing category
ANDA
Marketing start
2026-01-14
Substance
ELTROMBOPAG OLAMINE
Active strength
12.5 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219638-001ELTROMBOPAG OLAMINEELTROMBOPAG OLAMINEEQ 12.5MG ACIDTABLET / ORALAB2026-01-14
A219638-002ELTROMBOPAG OLAMINEELTROMBOPAG OLAMINEEQ 25MG ACIDTABLET / ORALAB2026-01-14
A219638-003ELTROMBOPAG OLAMINEELTROMBOPAG OLAMINEEQ 50MG ACIDTABLET / ORALAB2026-01-14
A219638-004ELTROMBOPAG OLAMINEELTROMBOPAG OLAMINEEQ 75MG ACIDTABLET / ORALAB2026-01-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A219638-001AB
A219638-002AB
A219638-003AB
A219638-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A219638-001ELTROMBOPAG OLAMINEEQ 12.5MG ACIDTABLET / ORALAB2026-01-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219638-002ELTROMBOPAG OLAMINEEQ 25MG ACIDTABLET / ORALAB2026-01-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219638-003ELTROMBOPAG OLAMINEEQ 50MG ACIDTABLET / ORALAB2026-01-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219638-004ELTROMBOPAG OLAMINEEQ 75MG ACIDTABLET / ORALAB2026-01-14011fe1cb6892…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219638-001ELTROMBOPAG OLAMINEEQ 12.5MG ACIDTABLET / ORALAB2026-01-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219638-002ELTROMBOPAG OLAMINEEQ 25MG ACIDTABLET / ORALAB2026-01-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219638-003ELTROMBOPAG OLAMINEEQ 50MG ACIDTABLET / ORALAB2026-01-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219638-004ELTROMBOPAG OLAMINEEQ 75MG ACIDTABLET / ORALAB2026-01-14a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A219638-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219638-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219638-003AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219638-004AB1011fe1cb6892…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219638-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219638-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219638-003AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219638-004AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Eltrombopag olamine
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ELTROMBOPAG OLAMINE12.5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4U07F515LGInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
825421Internal RxNorm lookup
825427Internal RxNorm lookup
884617Internal RxNorm lookup
1245001Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
604f663c-4933-402a-8105-5921713cf3c8Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
349df11e-99eb-4fff-8cd5-538adda21b14Product name320251110
4db6dd95-5e83-4752-b5e1-62f824423c50Product name120241217
fa996cde-a51d-4f68-1429-4f06c00a39f8Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70069-837-01Eltrombopag olamine30 in 1 BOTTLETABLET, FILM COATED307

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70069-837-01EA - Each70069-8373890d79b-f8f0-4446-a324-216b2f96980012026-02-05

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Eltrombopag olamineELTROMBOPAG OLAMINEAmerisyn, LLC52ba8e06-aa7d-caa6-e063-6294a90a5ce52026-06-30Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219638
application number: ANDA219638
Eltrombopag olamineELTROMBOPAG OLAMINESomerset Therapeutics, LLC604f663c-4933-402a-8105-5921713cf3c82026-01-13Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219638
application number: ANDA219638
ndc (product): 70069-837

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1245001eltrombopag 12.5 MG Oral TabletPSN604f663c-4933-402a-8105-5921713cf3c87
825421eltrombopag 25 MG Oral TabletPSN604f663c-4933-402a-8105-5921713cf3c87
825427eltrombopag 50 MG Oral TabletPSN604f663c-4933-402a-8105-5921713cf3c87
884617eltrombopag 75 MG Oral TabletPSN604f663c-4933-402a-8105-5921713cf3c87
1245001eltrombopag 12.5 MG Oral TabletSCD604f663c-4933-402a-8105-5921713cf3c87
825421eltrombopag 25 MG Oral TabletSCD604f663c-4933-402a-8105-5921713cf3c87
825427eltrombopag 50 MG Oral TabletSCD604f663c-4933-402a-8105-5921713cf3c87
884617eltrombopag 75 MG Oral TabletSCD604f663c-4933-402a-8105-5921713cf3c87
1245001eltrombopag (as eltrombopag olamine) 12.5 MG Oral TabletSY604f663c-4933-402a-8105-5921713cf3c87
825421eltrombopag (as eltrombopag olamine) 25 MG Oral TabletSY604f663c-4933-402a-8105-5921713cf3c87
825427eltrombopag (as eltrombopag olamine) 50 MG Oral TabletSY604f663c-4933-402a-8105-5921713cf3c87
884617eltrombopag (as eltrombopag olamine) 75 MG Oral TabletSY604f663c-4933-402a-8105-5921713cf3c87

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70069-837-017006908370130 TABLET, FILM COATED in 1 BOTTLE (70069-837-01) 2026-01-14NoNoCurrent